NephrologyOnline.net

Nephrology Xagena

Search results for "Hyperphosphatemia"

The FDA ( Food and Drug Administration ) has approved Zemplar ( Paricalcitol ) capsules, an oral, activated vitamin D therapy for prevention and treatment of secondary hyperparathyroidism ( SHPT ). ...


A study has assessed the effects and safety of iron-based phosphate binders in adult patients receiving dialysis. Eight studies with 2018 participants were eligible for the meta-analysis. Iron- ...


Abnormal mineral metabolism is a hallmark in patients with advanced chronic kidney disease ( CKD ). Hyperphosphatemia, and the homeostatic mechanisms controlling phosphate metabolism, have received pa ...


Endothelial dysfunction underlies multiple cardiovascular consequences of chronic kidney disease ( CKD ) and antecedent diabetes or hypertension. Endothelial insults in chronic kidney disease or end-s ...